Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Eckert-Ziegler Bebig

+ Add to Watchlist


1.229 EUR 0.013 1.05%

As of 02:02:14 ET on 04/21/2015.

Snapshot for Eckert-Ziegler Bebig (IBY)

Open: 1.229 Day's Range: 1.229 - 1.229 Volume: 0
Previous Close: 1.242 52wk Range: 1.211 - 1.940 1-Yr Rtn: -36.02%

Stock Chart for IBY

No chart data available.
  • IBY:GR 1.229
  • 1M
  • 1Y
Interactive IBY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IBY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 21.57
Shares Outstanding (M) 17.55
30 Day Average Volume 14
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IBY

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for IBY

Eckert-Ziegler Bebig manufactures and markets radioactive implants and medications used in the treatment of cancer. The Company's implants are a localized treatment that kills the cancer without damaging the surrounding tissues. Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing of its product line.

Edgar LoefflerJoint Managing DirectorAbel LuzuriagaJoint Managing Director
More Company Profile & Key Executives for IBY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil